NO20092018L - Fremgangsmater for a behandle depresjon - Google Patents

Fremgangsmater for a behandle depresjon

Info

Publication number
NO20092018L
NO20092018L NO20092018A NO20092018A NO20092018L NO 20092018 L NO20092018 L NO 20092018L NO 20092018 A NO20092018 A NO 20092018A NO 20092018 A NO20092018 A NO 20092018A NO 20092018 L NO20092018 L NO 20092018L
Authority
NO
Norway
Prior art keywords
treating depression
methods
depression
formula
treating
Prior art date
Application number
NO20092018A
Other languages
English (en)
Inventor
Robert Gordon
Yong Moon Choi
Magali Haas
Ewa Malatynska
Original Assignee
Sk Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092018(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Holdings filed Critical Sk Holdings
Publication of NO20092018L publication Critical patent/NO20092018L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives en fremgangsmåte for behandling av depresjon omfattende administrering til et individ som trenger det av en terapeutisk effektiv mengde av en eller flere karbamatforbindelser med formel 1 og/eller formel 2 som definert her og som vist nedenfor for behandling av depresjon. Formlene 1 og 2 er rettet mot en fremgangsmåte for behandling av depresjon som inkluderer monoterapi og alternativt koterapi med minst et ytterligere antidepressivt virkestoff.
NO20092018A 2006-10-30 2009-05-25 Fremgangsmater for a behandle depresjon NO20092018L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30
PCT/US2007/082069 WO2008055022A2 (en) 2006-10-30 2007-10-22 Carbamate compounds for use in treating depression

Publications (1)

Publication Number Publication Date
NO20092018L true NO20092018L (no) 2009-05-26

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092018A NO20092018L (no) 2006-10-30 2009-05-25 Fremgangsmater for a behandle depresjon

Country Status (22)

Country Link
US (1) US20080317883A1 (no)
EP (1) EP2081648A2 (no)
JP (1) JP2010508355A (no)
KR (1) KR20090110889A (no)
CN (1) CN101568362A (no)
AR (1) AR064241A1 (no)
AU (1) AU2007313865A1 (no)
BR (1) BRPI0718324A2 (no)
CA (1) CA2667949A1 (no)
CL (1) CL2007003120A1 (no)
EA (1) EA200970436A1 (no)
EC (1) ECSP099308A (no)
IL (1) IL198484A0 (no)
MX (1) MX2009004770A (no)
NI (1) NI200900073A (no)
NO (1) NO20092018L (no)
PE (1) PE20080929A1 (no)
SV (1) SV2009003247A (no)
TW (1) TW200835477A (no)
UY (1) UY30675A1 (no)
WO (1) WO2008055022A2 (no)
ZA (1) ZA200903771B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CA2815460C (en) 2011-01-13 2017-04-18 Bio-Pharm Solutions Co., Ltd. Process for preparation of phenyl carbamate derivatives
EP2797880B1 (en) 2011-12-27 2017-03-01 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
CN116478225B (zh) * 2023-04-12 2024-06-11 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
MXPA03007717A (es) * 2001-02-27 2005-11-08 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o tratamiento de trastornos bipolares.
PL364640A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
US6541513B2 (en) * 2001-02-27 2003-04-01 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating psychotic disorders
PL364680A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
CA2587481A1 (en) * 2004-10-28 2006-05-11 Sk Corporation Phenylalkylamino carbamates adjunctive therapy for depression

Also Published As

Publication number Publication date
KR20090110889A (ko) 2009-10-23
EA200970436A1 (ru) 2009-12-30
JP2010508355A (ja) 2010-03-18
UY30675A1 (es) 2008-05-02
IL198484A0 (en) 2011-08-01
CA2667949A1 (en) 2008-05-08
AU2007313865A1 (en) 2008-05-08
ECSP099308A (es) 2009-10-30
TW200835477A (en) 2008-09-01
NI200900073A (es) 2010-02-25
WO2008055022A3 (en) 2008-06-19
BRPI0718324A2 (pt) 2013-11-26
US20080317883A1 (en) 2008-12-25
WO2008055022A2 (en) 2008-05-08
PE20080929A1 (es) 2008-07-19
CN101568362A (zh) 2009-10-28
SV2009003247A (es) 2009-11-24
EP2081648A2 (en) 2009-07-29
CL2007003120A1 (es) 2008-07-18
ZA200903771B (en) 2010-08-25
AR064241A1 (es) 2009-03-25
MX2009004770A (es) 2009-08-17

Similar Documents

Publication Publication Date Title
NO20092018L (no) Fremgangsmater for a behandle depresjon
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
MX2009011867A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
NO20083005L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av smerte
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EA201270570A1 (ru) Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
WO2007095618A3 (en) Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
WO2007112000A3 (en) Treatment of pain
NO20076357L (no) Azabicykliske heterocykler som cannabinoid reseptor modulatorer
WO2009134616A3 (en) Novel inhibitors of hepatitis c virus replication
WO2007101232A3 (en) Inhibition of jak2 as a treatment of pulmonary arterial hypertension
WO2007095615A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
DK2040703T3 (da) Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf
ATE522500T1 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
TW200639159A (en) Treatment of pain
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
NO20091659L (no) Fremgangsmater for behandling av disruptive oppforselsforstyrrelser
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application